Preventable premature mortality
New technologies and advances in health sciences make it possible to avoid a considerable proportion of premature deaths by adopting appropriate preventive and predictive measures, with timely medical care. This type of mortality is known as potentially avoidable premature mortality (PPPM).
The WHO emphasizes that premature death in people under 75 years of age can be reduced through early health interventions or through quality care if the diseases or conditions have already developed.
The specialized Longevytum Medical Unit has a powerful analytical and imaging battery focused on PPPM, with biochemical, molecular biology, and genetic analyses, as well as a multitude of determinations, including: oxidative, inflammatory, hormonal, and coagulation profiles, stress tests, gut microbiome, intestinal dysbiosis, and toxic metals; cardiovascular profile with its lipid alterations; neurodegenerative profile; and tumor profile.
What are we studying to prevent preventable premature mortality?
We will direct our laboratory and imaging tests to the two main causes of this mortality: cardiovascular disease and cancer.
- Cardiovascular assessment: First, we will obtain a detailed and thorough medical history of the patient to specifically direct the diagnostic tests. We will use various specialized laboratory tests, which are not determined during routine health checkups and which miss important and valuable data. Lipids, lifestyle, and diet are not sufficient to accurately predict cardiovascular status, as 50% of heart attacks and other cardiovascular diseases occur in patients with normal LDL cholesterol. Therefore, we perform specific analytical tests, such as LDL-P by MRI, LipoA, the composition of fatty acids in the erythrocyte membrane, and, if necessary, the use of Genetic BioChips for greater accuracy. We also perform other types of tests, such as:
– Imaging tests: Doppler ultrasound of the arterial tree, carotid, aortic, iliac, and femoral, providing an assessment and prediction of cardiovascular risk.
– Coronary calcium score, to assess the risk of atherosclerosis and coronary artery disease. According to this, we would move on to the star test, the Coronary Angio-CT
– Coronary Angio-CT, a non-invasive imaging test that, after 320 CT image slices, visualizes in 3D the state of the coronary arteries and their possible partial obstructions, which could progress to a complete obstruction, with the consequent acute myocardial infarction, so common today in middle-aged people, with a fatal outcome in many cases. Therefore, it is a test with high predictive value. - Oncological evaluation: We will apply various special analytical tests for the prevention of different tumors: PSA, CEA, Alpha-Fetoprotein, CA 19.9, CA 15.3, CA 125, Septin 9 test, occult blood, H-pylori test. In addition to other, more specific tests, such as: – Low-Dose CT for lung cancer screening in smokers or ex-smokers.
– Body CT: Complete thoracoabdominal scan for tumor screening. MRI, especially of the brain, to assess gliosis/ischemia.
li>
Información y conceptos
Se refiere a aquellas muertes de personas menores de 75 años que pueden evitarse interviniendo tempranamente sobre la salud (cambios en la dieta, práctica deportiva…) o con intervención médica.
Conjunto de pruebas diagnósticas dirigidas a valorar el estado de forma del corazón y los vasos sanguíneos
Conjunto de pruebas diagnósticas dirigidas a detectar distintos tipos de cáncer, tanto en fase siliente como activos